India’s pharmaceutical industry is witnessing a surge in global partnerships, with countries such as Switzerland, Uzbekistan, ...

M&A was again a big feature in last week's news, with AbbVie’s acquisition of Apogee Therapeutics, along with its atopic ...

US biotech Viridian Therapeutics saw its shares climb more than 10% to $19.81 in after-hours activity Friday, when it ...

The European Commission (EC) has approved Maviret (glecaprevir/pibrentasvir) for the treatment of acute hepatitis C virus ...

The UK’s National Institute for Health and Care Excellence (NICE) has recommended the use of Keytruda (pembrolizumab), within ...

CNX Therapeutics and Legacy Pharma have entered into a US commercial partnership for the launch of Ethyol (amifostine), with ...

German drugmaker Merck KGaA said today it will acquire US biotech firm Bio-Techne Corp for $11.3 billion, expanding its ...

US biopharma Definium Therapeutics has closed an upsized public offering that raised $805 million in gross proceeds, days ...

US genomic medicine company Sangamo Therapeutics has filed for Chapter 11 bankruptcy protection as it prepares to auction off ...

Northern Ireland-based Galen has secured an expanded UK license for Penthrox (methoxyflurane), allowing the emergency pain ...

Paris and Boston, USA-based clinical-stage biotech Bionyra Pharma, which is developing next-generation biologics for ...

US biotech Ionis Pharmaceuticals yesterday announced that the US Food and Drug Administration (FDA) has approved Tryngolza ...